Online Database of Chemicals from Around the World
Search |  Submit |  中文
Home >> Categories of Chemicals >> Biochemical >>Inhibitor >>Angiogenesis >>Bcr-Abl inhibitor

Category of Chemicals

Bcr-Abl inhibitor

Bcr-Abl inhibitors are a remarkable class of medications developed to treat chronic myeloid leukemia (CML). This unique group of drugs, which includes imatinib and dasatinib, specifically targets the Bcr-Abl fusion protein that drives the growth of CML cells. By disrupting this aberrant protein, Bcr-Abl inhibitors have revolutionized the treatment of CML, providing patients with more extended and higher quality lives.

Products of Bcr-Abl inhibitor
CAS No.Product NameMolecular Formula
1020172-07-9DCC-2036C30H28FN7O3
1421783-64-3GZD 824C29H27F3N6O.2(CH4O3S)
260415-63-26-(2,6-Dichlorophenyl)-8-methyl-2-[[3-(methylthio)phenyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-oneC21H16Cl2N4OS
778270-11-4GNF-2C18H13F3N4O2
778277-15-9N-(2-Hydroxyethyl)-3-[6-[[4-(trifluoromethoxy)phenyl]amino]-4-pyrimidinyl]benzamideC20H17F3N4O3
856243-80-6WP 1130C19H18BrN3O
943319-70-8PonatinibC29H27F3N6O


©  chemBlink. All rights reserved.  Content Disclaimer  |  About chemBlink  |  Contact